Ardelyx Inc (ARDX)
5.12
+0.20
(+4.07%)
USD |
NASDAQ |
Nov 21, 15:39
Ardelyx Price to Book Value: 7.661 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 7.362 |
November 19, 2024 | 7.167 |
November 18, 2024 | 7.422 |
November 15, 2024 | 7.436 |
November 14, 2024 | 7.047 |
November 13, 2024 | 6.733 |
November 12, 2024 | 6.868 |
November 11, 2024 | 7.324 |
November 08, 2024 | 7.586 |
November 07, 2024 | 9.546 |
November 06, 2024 | 9.711 |
November 05, 2024 | 8.559 |
November 04, 2024 | 8.813 |
November 01, 2024 | 9.112 |
October 31, 2024 | 8.783 |
October 30, 2024 | 8.813 |
October 29, 2024 | 8.993 |
October 28, 2024 | 8.828 |
October 25, 2024 | 8.634 |
October 24, 2024 | 8.770 |
October 23, 2024 | 8.350 |
October 22, 2024 | 8.650 |
October 21, 2024 | 8.799 |
October 18, 2024 | 8.740 |
October 17, 2024 | 8.725 |
Date | Value |
---|---|
October 16, 2024 | 8.754 |
October 15, 2024 | 8.934 |
October 14, 2024 | 8.964 |
October 11, 2024 | 9.039 |
October 10, 2024 | 9.039 |
October 09, 2024 | 8.784 |
October 08, 2024 | 8.919 |
October 07, 2024 | 9.174 |
October 04, 2024 | 10.21 |
October 03, 2024 | 9.967 |
October 02, 2024 | 10.37 |
October 01, 2024 | 10.25 |
September 30, 2024 | 10.31 |
September 27, 2024 | 10.65 |
September 26, 2024 | 10.19 |
September 25, 2024 | 9.722 |
September 24, 2024 | 9.498 |
September 23, 2024 | 9.482 |
September 20, 2024 | 9.818 |
September 19, 2024 | 9.594 |
September 18, 2024 | 9.450 |
September 17, 2024 | 9.850 |
September 16, 2024 | 9.962 |
September 13, 2024 | 10.11 |
September 12, 2024 | 9.962 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.027
Minimum
Feb 23 2022
14.98
Maximum
Dec 19 2019
5.417
Average
4.890
Median
Mar 26 2021
Price to Book Value Benchmarks
Verve Therapeutics Inc | 0.7708 |
United Therapeutics Corp | 2.688 |
Zoetis Inc | 15.20 |
NovaBay Pharmaceuticals Inc | 3.121 |
Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 4.757 |
PEG Ratio | -0.1014 |
Price | 5.12 |
Earnings Yield | -6.12% |
Market Cap | 1.213B |
PEGY Ratio | -0.1014 |